BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 33757300)

  • 1.
    Pal D; Riester SM; Hasan B; Tufa SF; Dudakovic A; Keene DR; van Wijnen AJ; Schweitzer R
    Stem Cells Dev; 2021 Jun; 30(11):601-609. PubMed ID: 33757300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic Control of Skeletal Development by the Histone Methyltransferase Ezh2.
    Dudakovic A; Camilleri ET; Xu F; Riester SM; McGee-Lawrence ME; Bradley EW; Paradise CR; Lewallen EA; Thaler R; Deyle DR; Larson AN; Lewallen DG; Dietz AB; Stein GS; Montecino MA; Westendorf JJ; van Wijnen AJ
    J Biol Chem; 2015 Nov; 290(46):27604-17. PubMed ID: 26424790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancer of zeste homolog 2 (
    Dudakovic A; Camilleri ET; Paradise CR; Samsonraj RM; Gluscevic M; Paggi CA; Begun DL; Khani F; Pichurin O; Ahmed FS; Elsayed R; Elsalanty M; McGee-Lawrence ME; Karperien M; Riester SM; Thaler R; Westendorf JJ; van Wijnen AJ
    J Biol Chem; 2018 Aug; 293(33):12894-12907. PubMed ID: 29899112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EZH2 deletion in early mesenchyme compromises postnatal bone microarchitecture and structural integrity and accelerates remodeling.
    Hemming S; Cakouros D; Codrington J; Vandyke K; Arthur A; Zannettino A; Gronthos S
    FASEB J; 2017 Mar; 31(3):1011-1027. PubMed ID: 27934660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple pharmacological inhibitors targeting the epigenetic suppressor enhancer of zeste homolog 2 (Ezh2) accelerate osteoblast differentiation.
    Galvan ML; Paradise CR; Kubrova E; Jerez S; Khani F; Thaler R; Dudakovic A; van Wijnen AJ
    Bone; 2021 Sep; 150():115993. PubMed ID: 33940225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effective role of Curcumin on expression regulation of EZH2 histone methyltransferase as a dynamic epigenetic factor in osteogenic differentiation of human mesenchymal stem cells.
    Ghorbaninejad M; Khademi-Shirvan M; Hosseini S; Meyfour A; Shahhoseini M; Baghaban Eslaminejad M
    Biochim Biophys Acta Gene Regul Mech; 2023 Mar; 1866(1):194903. PubMed ID: 36538966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of histone methyltransferase Ezh2 stimulates an osteogenic transcriptional program in chondrocytes but does not affect cartilage development.
    Camilleri ET; Dudakovic A; Riester SM; Galeano-Garces C; Paradise CR; Bradley EW; McGee-Lawrence ME; Im HJ; Karperien M; Krych AJ; Westendorf JJ; Larson AN; van Wijnen AJ
    J Biol Chem; 2018 Dec; 293(49):19001-19011. PubMed ID: 30327434
    [No Abstract]   [Full Text] [Related]  

  • 8. The regulatory proteins DSCR6 and Ezh2 oppositely regulate Stat3 transcriptional activity in mesoderm patterning during
    Loreti M; Shi DL; Carron C
    J Biol Chem; 2020 Feb; 295(9):2724-2735. PubMed ID: 31996376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coordinated development of the limb musculoskeletal system: Tendon and muscle patterning and integration with the skeleton.
    Huang AH
    Dev Biol; 2017 Sep; 429(2):420-428. PubMed ID: 28363737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancer of Zeste Homolog 2 Inhibition Stimulates Bone Formation and Mitigates Bone Loss Caused by Ovariectomy in Skeletally Mature Mice.
    Dudakovic A; Camilleri ET; Riester SM; Paradise CR; Gluscevic M; O'Toole TM; Thaler R; Evans JM; Yan H; Subramaniam M; Hawse JR; Stein GS; Montecino MA; McGee-Lawrence ME; Westendorf JJ; van Wijnen AJ
    J Biol Chem; 2016 Nov; 291(47):24594-24606. PubMed ID: 27758858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of the epigenetic suppressor EZH2 primes osteogenic differentiation mediated by BMP2.
    Dudakovic A; Samsonraj RM; Paradise CR; Galeano-Garces C; Mol MO; Galeano-Garces D; Zan P; Galvan ML; Hevesi M; Pichurin O; Thaler R; Begun DL; Kloen P; Karperien M; Larson AN; Westendorf JJ; Cool SM; van Wijnen AJ
    J Biol Chem; 2020 Jun; 295(23):7877-7893. PubMed ID: 32332097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel insights of EZH2-mediated epigenetic modifications in degenerative musculoskeletal diseases.
    Ma Z; Chen L; Wang Y; Zhang S; Zheng J; Luo Y; Wang C; Zeng H; Xue L; Tan Z; Wang D
    Ageing Res Rev; 2023 Sep; 90():102034. PubMed ID: 37597667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stage-specific roles of Ezh2 and Retinoic acid signaling ensure calvarial bone lineage commitment.
    Ferguson JW; Devarajan M; Atit RP
    Dev Biol; 2018 Nov; 443(2):173-187. PubMed ID: 30222957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hox11 genes are required for regional patterning and integration of muscle, tendon and bone.
    Swinehart IT; Schlientz AJ; Quintanilla CA; Mortlock DP; Wellik DM
    Development; 2013 Nov; 140(22):4574-82. PubMed ID: 24154528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Novel EZH2 Targets Regulating Osteogenic Differentiation in Mesenchymal Stem Cells.
    Hemming S; Cakouros D; Vandyke K; Davis MJ; Zannettino AC; Gronthos S
    Stem Cells Dev; 2016 Jun; 25(12):909-21. PubMed ID: 27168161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EZH2 and KDM6A act as an epigenetic switch to regulate mesenchymal stem cell lineage specification.
    Hemming S; Cakouros D; Isenmann S; Cooper L; Menicanin D; Zannettino A; Gronthos S
    Stem Cells; 2014 Mar; 32(3):802-15. PubMed ID: 24123378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EZH2 Supports Osteoclast Differentiation and Bone Resorption Via Epigenetic and Cytoplasmic Targets.
    Adamik J; Pulugulla SH; Zhang P; Sun Q; Lontos K; Macar DA; Auron PE; Galson DL
    J Bone Miner Res; 2020 Jan; 35(1):181-195. PubMed ID: 31487061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EZH2 deletion promotes spermatogonial differentiation and apoptosis.
    Jin C; Zhang Y; Wang ZP; Wang XX; Sun TC; Li XY; Tang JX; Cheng JM; Li J; Chen SR; Deng SL; Liu YX
    Reproduction; 2017 Nov; 154(5):615-625. PubMed ID: 28982932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of EZH2 Promotes Human Embryonic Stem Cell Differentiation into Mesoderm by Reducing H3K27me3.
    Yu Y; Deng P; Yu B; Szymanski JM; Aghaloo T; Hong C; Wang CY
    Stem Cell Reports; 2017 Sep; 9(3):752-761. PubMed ID: 28826853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deletion of the Polycomb-Group Protein EZH2 Leads to Compromised Self-Renewal and Differentiation Defects in Human Embryonic Stem Cells.
    Collinson A; Collier AJ; Morgan NP; Sienerth AR; Chandra T; Andrews S; Rugg-Gunn PJ
    Cell Rep; 2016 Dec; 17(10):2700-2714. PubMed ID: 27926872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.